A Potential Treatment for Glioblastoma Using Nanoparticle
A novel nanoparticle treatment for glioblastoma has been developed by Northwestern Medicine investigators, as per the research published in Nature Communications.
Stay updated with breaking news from Michaelj Marchese. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel nanoparticle treatment for glioblastoma has been developed by Northwestern Medicine investigators, as per the research published in Nature Communications.
Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according to findings published in Proceedings of the National Academy of Sciences.
Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months.